<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-90227</identifier>
<setSpec>1139-9287</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Effect of raloxifene (a Selective Estrogen Receptor Modulator [SERM]) as coadjuvant to antidepressant treatment: A case report</dc:title>
<dc:description xml:lang="en">We report a case of a woman with a depressive disorder with partial response to antidepressant treatment. Raloxifene, a Selective Estrogen Receptor Modulator (SERM) was added to the treatment, the patient achieving complete remission of her depressive symptoms. The interest of our case lies in the fact that it exemplifies the relationship between depressive disorders and hormonal changes during menopause. Furthermore, raloxifene may become a novel therapeutic option in some postmenopausal women who do not respond or only partially respond to SSRIs, especially in those with a history of depressive disorders related to menopause (AU)</dc:description>
<dc:creator>Coromina, Marta</dc:creator>
<dc:creator>Usall, Judith</dc:creator>
<dc:creator>Ochoa, Susana</dc:creator>
<dc:creator>Araya, Susana</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se presenta el caso de una paciente con un trastorno depresivo con respuesta parcial al tratamiento antidepresivo. A la paciente se le añadió raloxifeno, Modulador Selectivo del Receptor Estrogénico (SERM), y se consiguió una remisión completa del episodio depresivo que presentaba. El interés de nuestro caso radica en el hecho que ejemplifica la relación entre los trastornos depresivos y los cambios hormonales durante la menopausia. Además, el raloxifeno  puede ser una nueva opción terapéutica en algunas mujeres en la postmenopausia que no responden o lo hacen de forma parcial a los ISRS, especialmente en aquellas con historia de trastornos depresivos relacionados con la menopausia (AU)</dc:description>
<dc:source>Actas Esp Psiquiatr;39(5): 334-335, sept.-oct. 2011.</dc:source>
<dc:identifier>ibc-90227</dc:identifier>
<dc:title xml:lang="es">Efecto del raloxifeno (Modulador Selectivo del Receptor Estrogénico (SERM)) como coadyuvante del tratamiento antidepresivo. A propósito de un caso</dc:title>
<dc:subject>^d34394^s22073</dc:subject>
<dc:subject>^d34394^s22000</dc:subject>
<dc:subject>^d34394^s22055</dc:subject>
<dc:subject>^d3886^s22053</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d34394^s22048</dc:subject>
<dc:subject>^d3886^s22054</dc:subject>
<dc:subject>^d3886^s22034</dc:subject>
<dc:subject>^d3886^s22056</dc:subject>
<dc:subject>^d3886^s22024</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d3886^s22016</dc:subject>
<dc:subject>^d31157^s22056</dc:subject>
<dc:subject>^d3886^s22027</dc:subject>
<dc:subject>^d31157^s22028</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:type>article</dc:type>
<dc:date>201110</dc:date>
</metadata>
</record>
</ibecs-document>
